129 related articles for article (PubMed ID: 17591314)
61. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
Shami VM; Caldwell SH; Hespenheide EE; Arseneau KO; Bickston SJ; Macik BG
Liver Transpl; 2003 Feb; 9(2):138-43. PubMed ID: 12548507
[TBL] [Abstract][Full Text] [Related]
62. Successful use of recombinant factor VII in massive hemoptysis due to community-acquired pneumonia.
Macdonald JA; Fraser JF; Foot CL; Tran K
Chest; 2006 Aug; 130(2):577-9. PubMed ID: 16899862
[TBL] [Abstract][Full Text] [Related]
63. Recombinant activated coagulation factor VII and bleeding trauma patients.
Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
[TBL] [Abstract][Full Text] [Related]
64. Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor.
Laguna P; Klukowska A
Haemophilia; 2005 Jan; 11(1):2-4. PubMed ID: 15660981
[TBL] [Abstract][Full Text] [Related]
65. Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass.
Naik VN; Mazer CD; Latter DA; Teitel JM; Hare GM
Can J Anaesth; 2003; 50(6):599-602. PubMed ID: 12826554
[TBL] [Abstract][Full Text] [Related]
66. [A patient with repeated, life-threatening gastro-intestinal haemorrhages treated by means of medication, open surgery, endoscopic surgery, intervention radiology and conservative methods].
Vlaar AP; van Soest EJ; Levi M; van Lienden KP; Boermeester M; de Jonge E
Ned Tijdschr Geneeskd; 2007 Jun; 151(25):1412-7. PubMed ID: 17668608
[TBL] [Abstract][Full Text] [Related]
67. Recombinant activated factor VIIa to treat refractory lower gastrointestinal hemorrhage in a patient with recently implanted mechanical valve: a case report.
Omar AS; Sudarsanan S; Ewila H; Kindawi A
BMC Res Notes; 2014 Aug; 7():535. PubMed ID: 25128016
[TBL] [Abstract][Full Text] [Related]
68. Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation.
Kogan A; Berman M; Kassif Y; Raanani E; Stamler A; Ben Gal T; Stein M; Erez E; Vidne BA; Sahar G
J Heart Lung Transplant; 2005 Mar; 24(3):347-9. PubMed ID: 15737765
[TBL] [Abstract][Full Text] [Related]
69. [Hemostatic treatment for intractable traumatic hemorrhage using fibrinogen concentrates and recombinant activated factor VII].
Fujii T; Saito S
Rinsho Ketsueki; 2014 Feb; 55(2):234-8. PubMed ID: 24598191
[TBL] [Abstract][Full Text] [Related]
70. Case report: management of life-threatening oropharyngeal bleeding with recombinant factor VIIa.
Riazi S; Karkouti K; Heggie J
Can J Anaesth; 2006 Sep; 53(9):881-4. PubMed ID: 16960265
[TBL] [Abstract][Full Text] [Related]
71. An unusual complication of ice skating and the emergence of a previously undiagnosed bleeding disorder.
Mainwaring CJ; Pleydell-Pearce J; Chana J; Evans J; Roy A; Lewis H
Haemophilia; 2006 Sep; 12(5):551-4. PubMed ID: 16919089
[TBL] [Abstract][Full Text] [Related]
72. [Recombinant factor VII in the treatment of acute hemorrhage due to esophageal varices].
Jiménez-Sáenz M; Romero-Castro R
Gastroenterol Hepatol; 2005; 28(6):333-6. PubMed ID: 15989815
[No Abstract] [Full Text] [Related]
73. Recombinant factor VIIa: a useful tool for life-threatening colonic bleeding. Report of a case.
Mitchell JG; Speake WJ; Russell NK; Girling K; Armitage NC
Dis Colon Rectum; 2007 Dec; 50(12):2238-40. PubMed ID: 17917781
[No Abstract] [Full Text] [Related]
74. [Use of activated factor VII in severe acute hemorrhage].
Milano Manso G; Rodríguez Amuedo F; Aragonés Manzanero R; Martínez Ferriz MC; Oliva Muñoz C; Calvo Macias C
An Pediatr (Barc); 2005 May; 62(5):467-70. PubMed ID: 15871829
[TBL] [Abstract][Full Text] [Related]
75. Recombinant factor VIIa in intractable bleeding due to severe mediastinitis.
Feltracco P; Barbieri S; Michieletto E; Ori C
J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):761-2. PubMed ID: 17023308
[No Abstract] [Full Text] [Related]
76. Acute massive hemorrhage from intestinal Crohn disease. Report of seven cases and review of the literature.
Homan WP; Tang CK; Thorbjarnarson B
Arch Surg; 1976 Aug; 111(8):901-5. PubMed ID: 1085142
[TBL] [Abstract][Full Text] [Related]
77. Successful Hemostasis with Recombinant Activated Factor VII in a Patient with Massive Hepatic Subcapsular Hematoma.
Lee JH; Chae HB; Seo EK; Jeon WJ; Jeong HW; Shin YM; Bae JW; Kwon SK; Bae IH; Shim WS; Shin DI; Sung R; Kim JY
Case Rep Gastroenterol; 2009 Feb; 3(1):10-15. PubMed ID: 20651958
[TBL] [Abstract][Full Text] [Related]
78. Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy.
Anantharaju A; Mehta K; Mindikoglu AL; Van Thiel DH
Dig Dis Sci; 2003 Jul; 48(7):1414-24. PubMed ID: 12870806
[TBL] [Abstract][Full Text] [Related]
79. Ineffective off-label use of recombinant activated factor VII in a case of bone-marrow transplantation-related gastrointestinal bleeding.
Eller P; Pechlaner C; Wiedermann C
Thromb J; 2006 Jan; 4():1. PubMed ID: 16420687
[TBL] [Abstract][Full Text] [Related]
80. Massive gastrointestinal bleeding in Crohn's disease.
Dent MT; Freeman AH; Dickinson RJ
J R Soc Med; 1985 Aug; 78(8):628-9. PubMed ID: 3874960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
